Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADENO-beta betamethasone trial in children with symptomatic adenovirus infection
2022-002955-20Phase 3Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in adenoviral infection comparing Betamethasone with Placebo (2 arms). Primary endpoint: Fever resolution by 24 hours. Started Jan 2023; status: active.
02
Drugs
betamethasone
03
Conditions
adenoviral infection
Beyond the preview
Go deeper on 2022-002955-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002955-20.